Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: A new twist?

I think you're mading the assumption that the seller has enough shares to influence the stock price, and is willing to take a loss if wrong.

Here is where Swartz has the advantage. He can not lose, even if he is wrong.

Do you disagree? Opty

Share
New Message
Please login to post a reply